(Q58010175)

English

A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis

No description defined

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis (English)

0 references

polycythemia vera

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic idiopathic myelofibrosis

1 reference

based on heuristic

inferred from title

object named as

A Salar

7

0 references

Lourdes Florensa

object named as

L Florensa

4

0 references

author name string

B Bellosillo

1

0 references

L Martínez-Avilés

2

0 references

E Gimeno

3

0 references

R Longarón

5

0 references

G Navarro

6

0 references

B Espinet

8

0 references

F Solé

9

0 references

S Serrano

10

0 references

C Besses

11

0 references

publication date

15 March 2007

0 references

0 references

21

0 references

6

0 references

1331-1332

0 references

JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

21 January 2018

JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

21 January 2018

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

21 January 2018

Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

21 January 2018

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

21 January 2018

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

21 January 2018

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

7 January 2021

based on heuristic

inferred from DOI database lookup

Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404649

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404649

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58010175&oldid=2213718969"